Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

No differences of butyrylcholinesterase protein activity and allele frequency in Lewy body diseases.

Neurobiology of disease - 1 Aug 2009

Maetzler Walter, Keller Stefanie, Michelis Joan, Koehler Niklas, Stransky Elke, Becker Clemens, Schulte Claudia, Melms Arthur, Gasser Thomas, Berg Daniela

Abstract excerpt

Butyrylcholinesterase (BChE) genotypes and protein (BuChE) activity, especially in combination with Apolipoprotein E4 (ApoE4), have been investigated as risk factors for developing Alzheimer disease (AD) and may be associated with the rate of progression of cognitive decline. Despite similar pathologic (e.g. amyloid deposition) and neurochemical (e.g. cholinergic deficits) aspects between AD and Lewy body...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aging
Share to Apolipoprotein E4

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Butyrylcholinesterase

Share to Cognition

Share to Cognition Disorders

Share to Enzymes

Share to Lewy Body Disease

Share to Sex Characteristics

Source

Identifiers

PMID: 19481150
DOI: 10.1016/j.nbd.2009.05.014

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

No differences of butyrylcholinesterase protein activity and allele frequency in Lewy body diseases.PMID 19481150Read ↗

Association between butyrylcholinesterase and cerebrospinal fluid biomarkers in Alzheimer's disease patients.Semantic proximity Read ↗

Plasma butyrylcholinesterase activity: a possible biomarker for differential diagnosis between Alzheimer's disease and dementia with Lewy bodies?Semantic proximity Read ↗

BuChE K variant is decreased in Alzheimer's disease not in fronto-temporal dementia.Semantic proximity Read ↗

Association of Butyrylcholinesterase-K Allele and Apolipoprotein E ɛ4 Allele with Cognitive Decline in Dementia with Lewy Bodies and Alzheimer's Disease.Semantic proximity Read ↗

Apolipoprotein ε4 modulates phenotype of butyrylcholinesterase in CSF of patients with Alzheimer's disease.Semantic proximity Read ↗

Differential CSF butyrylcholinesterase levels in Alzheimer's disease patients with the ApoE epsilon4 allele, in relation to cognitive function and cerebral glucose metabolism.Semantic proximity Read ↗

The apolipoprotein E ε4 allele plays pathological roles in AD through high protein expression and interaction with butyrylcholinesterase.Semantic proximity Read ↗

BuChE-K and APOE epsilon4 allele frequencies in Lewy body dementias, and influence of genotype and hyperhomocysteinemia on cognitive decline.Semantic proximity Read ↗

Influence of Butyrylcholinesterase in Progression of Mild Cognitive Impairment to Alzheimer's Disease.Semantic proximity Read ↗

Butyrylcholinesterase K variant associated with higher enzyme activity in the temporal cortex of elderly patients.Semantic proximity Read ↗

Butyrylcholinesterase, ApoE and Alzheimer's disease in a population from the Canary Islands (Spain).Semantic proximity Read ↗

Butyrylcholinesterase K variant and Alzheimer's disease risk: a meta-analysis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.